如何促进低收入国家的患者更早进入抗逆转录病毒治疗项目？ - Suppr

Suppr

超能文献

How can earlier entry of patients into antiretroviral programs in low-income countries be promoted?

作者信息

Lawn Stephen D, Wood Robin

出版信息

Clin Infect Dis. 2006 Feb 1;42(3):431-2; author reply 432-3. doi: 10.1086/499527.

DOI:10.1086/499527

PMID:16392093

Abstract

摘要

相似文献

How can earlier entry of patients into antiretroviral programs in low-income countries be promoted?

Clin Infect Dis. 2006 Feb 1;42(3):431-2; author reply 432-3. doi: 10.1086/499527.

Called to account.

Nature. 2004 Jul 8;430(6996):133. doi: 10.1038/430133a.

Efficacy of antiretroviral therapy in resource-poor settings: are outcomes comparable to those in the developed world?

Clin Infect Dis. 2005 Dec 1;41(11):1683-4; author reply 1684. doi: 10.1086/498030.

Rational use of antiretroviral therapy in low-income and middle-income countries: optimizing regimen sequencing and switching.

AIDS. 2008 Oct 18;22(16):2053-67. doi: 10.1097/QAD.0b013e328309520d.

Antiretroviral treatment for HIV infection in developing countries: an attainable new paradigm.

Nat Med. 2003 Dec;9(12):1449-52. doi: 10.1038/nm1203-1449.

[HIV therapy: tenofir DF is available in 68 developing countries at production costs price].

Med Klin (Munich). 2003 Jul 15;98(7):XV-XVI.

A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations.

Antiviral Res. 2008 Sep;79(3):143-65. doi: 10.1016/j.antiviral.2008.05.001. Epub 2008 Jun 2.

Closing the affordability gap for drugs in low-income countries.

N Engl J Med. 2007 Nov 15;357(20):1996-9. doi: 10.1056/NEJMp0706918.

The cost effectiveness of antiretroviral therapy for HIV disease.

N Engl J Med. 2001 Jul 5;345(1):68; author reply 68-9.

HIV-1 viral load testing cost in developing countries: what's new?

Expert Rev Mol Diagn. 2007 Nov;7(6):703-7. doi: 10.1586/14737159.7.6.703.

引用本文的文献

Cost-effectiveness of a combination strategy to enhance the HIV care continuum in Swaziland: Link4Health.

PLoS One. 2018 Sep 17;13(9):e0204245. doi: 10.1371/journal.pone.0204245. eCollection 2018.

Community-based ART distribution system can effectively facilitate long-term program retention and low-rates of death and virologic failure in rural Uganda.

AIDS Res Ther. 2015 Nov 12;12:37. doi: 10.1186/s12981-015-0077-4. eCollection 2015.

The Link4Health study to evaluate the effectiveness of a combination intervention strategy for linkage to and retention in HIV care in Swaziland: protocol for a cluster randomized trial.

Implement Sci. 2015 Jul 19;10:101. doi: 10.1186/s13012-015-0291-4.

Retention in HIV Care and Predictors of Attrition from Care among HIV-Infected Adults Receiving Combination Anti-Retroviral Therapy in Addis Ababa.

PLoS One. 2015 Jun 26;10(6):e0130649. doi: 10.1371/journal.pone.0130649. eCollection 2015.

Antiretroviral therapy for control of the HIV-associated tuberculosis epidemic in resource-limited settings.

Clin Chest Med. 2009 Dec;30(4):685-99, viii. doi: 10.1016/j.ccm.2009.08.010.

The effect of AIDS defining conditions on immunological recovery among patients initiating antiretroviral therapy at Joint Clinical Research Centre, Uganda.

AIDS Res Ther. 2009 Jul 24;6:17. doi: 10.1186/1742-6405-6-17.

The impact of gender and income on survival and retention in a South African antiretroviral therapy programme.

Trop Med Int Health. 2009 Jul;14(7):722-31. doi: 10.1111/j.1365-3156.2009.02290.x. Epub 2009 Apr 27.

Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review.

PLoS Med. 2007 Oct 16;4(10):e298. doi: 10.1371/journal.pmed.0040298.

Plasma levels of soluble urokinase-type plasminogen activator receptor (suPAR) and early mortality risk among patients enrolling for antiretroviral treatment in South Africa.

BMC Infect Dis. 2007 May 17;7:41. doi: 10.1186/1471-2334-7-41.

Gender distribution of adult patients on highly active antiretroviral therapy (HAART) in Southern Africa: a systematic review.

BMC Public Health. 2007 Apr 25;7:63. doi: 10.1186/1471-2458-7-63.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

How can earlier entry of patients into antiretroviral programs in low-income countries be promoted?

作者信息

Lawn Stephen D, Wood Robin

出版信息

Clin Infect Dis. 2006 Feb 1;42(3):431-2; author reply 432-3. doi: 10.1086/499527.

DOI:10.1086/499527

PMID:16392093

Abstract

摘要

相似文献

How can earlier entry of patients into antiretroviral programs in low-income countries be promoted?

Clin Infect Dis. 2006 Feb 1;42(3):431-2; author reply 432-3. doi: 10.1086/499527.

Called to account.

Nature. 2004 Jul 8;430(6996):133. doi: 10.1038/430133a.

Efficacy of antiretroviral therapy in resource-poor settings: are outcomes comparable to those in the developed world?

Clin Infect Dis. 2005 Dec 1;41(11):1683-4; author reply 1684. doi: 10.1086/498030.

Rational use of antiretroviral therapy in low-income and middle-income countries: optimizing regimen sequencing and switching.

AIDS. 2008 Oct 18;22(16):2053-67. doi: 10.1097/QAD.0b013e328309520d.

Antiretroviral treatment for HIV infection in developing countries: an attainable new paradigm.

Nat Med. 2003 Dec;9(12):1449-52. doi: 10.1038/nm1203-1449.

[HIV therapy: tenofir DF is available in 68 developing countries at production costs price].

Med Klin (Munich). 2003 Jul 15;98(7):XV-XVI.

A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations.

Antiviral Res. 2008 Sep;79(3):143-65. doi: 10.1016/j.antiviral.2008.05.001. Epub 2008 Jun 2.

Closing the affordability gap for drugs in low-income countries.

N Engl J Med. 2007 Nov 15;357(20):1996-9. doi: 10.1056/NEJMp0706918.

The cost effectiveness of antiretroviral therapy for HIV disease.

N Engl J Med. 2001 Jul 5;345(1):68; author reply 68-9.

HIV-1 viral load testing cost in developing countries: what's new?

Expert Rev Mol Diagn. 2007 Nov;7(6):703-7. doi: 10.1586/14737159.7.6.703.

引用本文的文献

Cost-effectiveness of a combination strategy to enhance the HIV care continuum in Swaziland: Link4Health.

PLoS One. 2018 Sep 17;13(9):e0204245. doi: 10.1371/journal.pone.0204245. eCollection 2018.

Community-based ART distribution system can effectively facilitate long-term program retention and low-rates of death and virologic failure in rural Uganda.

AIDS Res Ther. 2015 Nov 12;12:37. doi: 10.1186/s12981-015-0077-4. eCollection 2015.

The Link4Health study to evaluate the effectiveness of a combination intervention strategy for linkage to and retention in HIV care in Swaziland: protocol for a cluster randomized trial.

Implement Sci. 2015 Jul 19;10:101. doi: 10.1186/s13012-015-0291-4.

Retention in HIV Care and Predictors of Attrition from Care among HIV-Infected Adults Receiving Combination Anti-Retroviral Therapy in Addis Ababa.

PLoS One. 2015 Jun 26;10(6):e0130649. doi: 10.1371/journal.pone.0130649. eCollection 2015.

Antiretroviral therapy for control of the HIV-associated tuberculosis epidemic in resource-limited settings.

Clin Chest Med. 2009 Dec;30(4):685-99, viii. doi: 10.1016/j.ccm.2009.08.010.

The effect of AIDS defining conditions on immunological recovery among patients initiating antiretroviral therapy at Joint Clinical Research Centre, Uganda.

AIDS Res Ther. 2009 Jul 24;6:17. doi: 10.1186/1742-6405-6-17.

The impact of gender and income on survival and retention in a South African antiretroviral therapy programme.

Trop Med Int Health. 2009 Jul;14(7):722-31. doi: 10.1111/j.1365-3156.2009.02290.x. Epub 2009 Apr 27.

Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review.

PLoS Med. 2007 Oct 16;4(10):e298. doi: 10.1371/journal.pmed.0040298.

Plasma levels of soluble urokinase-type plasminogen activator receptor (suPAR) and early mortality risk among patients enrolling for antiretroviral treatment in South Africa.

BMC Infect Dis. 2007 May 17;7:41. doi: 10.1186/1471-2334-7-41.

Gender distribution of adult patients on highly active antiretroviral therapy (HAART) in Southern Africa: a systematic review.

BMC Public Health. 2007 Apr 25;7:63. doi: 10.1186/1471-2458-7-63.